JLL is headquartered in New York, while Water Street Healthcare Partners is based in Chicago.
Financial details of the acquisition were not disclosed.
The life sciences subsidiary provides supply chain, compliance, finance and technology support to biopharma and medical device companies.
Dohmen Life Science Services Subsidiary will merge with Water Street’s commercialization services platform. The group was formed last year after the merger of Alliance Life Sciences, Health Strategies Group and The Access Group.
After the transaction closes, the leadership team from Dohmen Life Science Services Subsidiary will report to the platform’s board of directors.
According to the release, after the acquisition, the platform will serve more than 300 of the top pharmaceutical, biotech and medical device companies. This will, the release said, make the platform the leading independent provider of commercialization services to life sciences companies.
The Dohmen Company launched the subsidiary in 2014.
“We built, launched and grew DLSS as a disruptive alternative to traditional models that aren’t well suited to serving companies with targeted therapies and smaller patient populations,” said CEO of the Dohmen Company Cynthia LaConte. “That’s why it was important for us to find partners that could not only scale the business but could add strategically important capabilities for our clients.”